Dacryocystorhinostomy without intubation with intraoperative mitomycin-c
Creators
- 1. Isra Postgraduate Inst. of Ophthalmology, Karachi (Pakistan)
- 2. Jinnah Postragraduate Medical Centre, Karachi (Pakistan)
Description
To evaluate the success rate and complications of intraoperative Mitomycin-C in dacryocystorhinostomy surgery. This study included total 90 eyes of 90 patients fulfilling the inclusion criteria.The surgical procedure of external DCR done with intraoperative Mitomycin-C with a neurosurgical cottonoid soaked with 0.2mg/ml. Mitomycin C was applied to the anastomosed flaps and osteotomy site for 10 minutes, without Silicon tube intubation. Surgery was done under local as well as general anesthesia. Patients were followed for 6 months. Out of 90 patients included in this study, only 2 patients complained of persistent epiphora after 6 months follow-up and were labeled as failed DCR. Remaining 88 had either no tearing or significant improvement of tearing after 6 months follow up and patent lacrimal system by syringing without pressure. Success rate in this procedure was 97.77% (p-value< 0.001). This study showed very high rate of success. Only complication noted was excessive nasal bleeding which was easily controlled. Intraoperative Mitomycin-C application in external DCR is safe, effective, cheap adjunct that helps to achieve good results of DCR surgery. (author)
Additional details
Publishing Information
- Journal Title
- JCPSP. Journal of the College of Physicians and Surgeons Pakistan
- Journal Volume
- 16
- Journal Issue
- 7
- Journal Page Range
- p. 476-478
- ISSN
- 1022-386X
INIS
- Country of Publication
- Pakistan
- Country of Input or Organization
- Pakistan
- INIS RN
- 38040956
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- ANESTHESIA; FIBROSIS; MITOMYCIN; MUTANTS; PATIENTS; STREPTOMYCES; SURGERY
- Descriptors DEC
- ANTI-INFECTIVE AGENTS; ANTIBIOTICS; ANTIMITOTIC DRUGS; ANTINEOPLASTIC DRUGS; BACTERIA; DRUGS; MEDICINE; MICROORGANISMS; ORGANIC COMPOUNDS; PATHOLOGICAL CHANGES